9103U |
Alfentanil Screen, Urine |
9132B |
Oxycodone Screen, Blood |
9132SP |
Oxycodone Screen, Serum/Plasma |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9176B |
Fentanyl and Metabolite Screen, Blood |
9176FL |
Fentanyl and Metabolite Screen, Fluid |
9176SP |
Fentanyl and Metabolite Screen, Serum/Plasma |
9176TI |
Fentanyl and Metabolite Screen, Tissue |
9264B |
Sufentanil Screen, Blood |
9264U |
Sufentanil Screen, Urine |
9288B |
Tramadol and Metabolite Screen, Blood |
9288FL |
Tramadol and Metabolite Screen, Fluid |
9288SP |
Tramadol and Metabolite Screen, Serum/Plasma |
9291H |
Fentanyl Screen, Hair |
9324B |
Methadone Screen, Blood |
9324SP |
Methadone Screen, Serum/Plasma |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9332B |
Hydrocodone Screen, Blood |
9332SP |
Hydrocodone Screen, Serum/Plasma |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |